Indonesian herbal diabetic drug to target EU and Asia
date:Jul 07, 2012
The patented herbal blend tablet Inlacin is made from two local Indonesian plants Lagerstroemia speciosa and Cinnamomum burmanii. Two clinical trial phases back its efficacy as a supportive treatment for Diabetes mellitus Type-2.

The product took six years for Dexa Laboratories to develop and has been on the market as a traditional herbal medicine for around a year in Indonesia. The firm has partnered with independent consulting firm Phytonet AG to push the product on a global scale.

Dr. Ce
1/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 11:52